BJL
VRTX icon

Brighton Jones LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Brighton Jones LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.02M Buy
+6,756
New +$3.15M 0.07% 206
2025
Q4 		– Sell
-4,693
Closed -$1.84M – 943
2025
Q3 		$1.84M Buy
4,693
+134
+3% +$56K 0.04% 237
2025
Q2 		$2.03M Sell
4,559
-1,862
-29% -$858K 0.06% 190
2025
Q1 		$3.11M Buy
6,421
+1,994
+45% +$929K 0.1% 119
2024
Q4 		$1.78M Buy
4,427
+579
+15% +$268K 0.05% 181
2024
Q3 		$1.79M Sell
3,848
-452
-11% -$217K 0.07% 144
2024
Q2 		$2.02M Buy
4,300
+3,171
+281% +$1.38M 0.07% 150
2024
Q1 		$472K Buy
1,129
+194
+21% +$82K 0.02% 360
2023
Q4 		$380K Sell
935
-129
-12% -$47.7K 0.02% 387
2023
Q3 		$370K Buy
1,064
+45
+4% +$15.7K 0.02% 353
2023
Q2 		$359K Buy
1,019
+60
+6% +$20.2K 0.02% 363
2023
Q1 		$302K Buy
959
+85
+10% +$25.5K 0.02% 375
2022
Q4 		$252K Sell
874
-369
-30% -$112K 0.02% 381
2022
Q3 		$360K Buy
1,243
+369
+42% +$106K 0.02% 300
2022
Q2 		$246K Buy
874
+29
+3% +$7.76K 0.01% 374
2022
Q1 		$221K Buy
+845
New +$201K 0.01% 454

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Brighton Jones LLC's VRTX Position: Q1 2026 in Review

Brighton Jones LLC opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 6,756 shares worth $3.02M. The stake represents 0.07% of the portfolio and ranks #206 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in VRTX as recently as Q3 2025.

Brighton Jones LLC first reported a position in VRTX in Q1 2022 and has held it in 16 quarters since. The position peaked at $3.11M in Q1 2025. 1,692 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Brighton Jones LLC held 6,756 shares of Vertex Pharmaceuticals worth $3.02M as of Q1 2026.
  • Vertex Pharmaceuticals was a new Brighton Jones LLC position in Q1 2026.
  • Vertex Pharmaceuticals made up 0.07% of Brighton Jones LLC's portfolio in Q1 2026, its #206 holding.
  • Brighton Jones LLC first reported a position in Vertex Pharmaceuticals in Q1 2022 and has held it in 16 quarters since.
  • Brighton Jones LLC's Vertex Pharmaceuticals position peaked at $3.11M in Q1 2025.
  • 1,692 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.